LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the U.S. Food and Drug Administration (FDA) ...

(MENAFN- EIN Presswire) EINPresswire/ -- The global bone growth stimulator market is expected to reach US$ 2.5 billion in 2026 and grow to US$ 3.7 billion by 2033, at a CAGR of 5.6% during the ...

Please provide your email address to receive an email when new articles are posted on . Xstim Inc. received FDA premarket application approval of its Xstim spine fusion stimulator. The device is ...

Bone Growth Stimulator Market Report by TBRC covers the bone growth stimulator market drivers and restraints, size, major players, and the impact of COVID-19 LONDON ...

According to a new market research report "Bone Growth Stimulators Market by Product (Device, Bone morphogenetic protein, PRP), Application (spinal fusion, Delayed Union & Non Union Bone Fracture, ...

DUBLIN--(BUSINESS WIRE)--The "Bone Growth Products Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Bone Growth Products Market was valued at USD ...

The global bone growth stimulator market is expected to reach USD 1.4 billion by 2025, according to a new report by Grand View Research, Inc. Escalating demand for noninvasive and minimally invasive ...

Please provide your email address to receive an email when new articles are posted on . Theragen Inc. has announced the issuance of a U.S. patent for the ActaStim-S, a spine fusion bone-growth ...

JACKSONVILLE, Fla, Oct. 4, 2022 /PRNewswire/ -- Medical device company Theragen is pleased to announce the issuance of its 2nd U.S, Patent in 3 months. This latest patent acknowledges ActaStim-S' ...

JACKSONVILLE, Fla., Aug. 18, 2022 /PRNewswire/ -- Medical device company Theragen is pleased to announce the issuance of a U.S. Patent acknowledging its innovative approach to the development of the ...